Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in NXTC — NextCure, Inc.

CIK 1533421 NEW YORK, NY
Back to NXTC Full portfolio

Position in NXTC

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,780
+$2,078 QoQ
Shares Held
1,738
+1268.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 30 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NXTC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. NXTC ranks #412 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in NXTC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,780 1,738
2025-06-30 $702 1,528
2025-03-31 $897 1,869
2024-12-31 $506 658
2024-06-30 $1,950 1,227
2024-03-31 $5,071 2,274
2023-12-31 $9,223 8,091
2023-09-30 $9,083 7,042
2023-06-30 $6,582 3,657
2023-03-31 $20,867 14,100
2022-12-31 $29,791 21,129
2022-09-30 $45,030 16,375
2022-06-30 $38,394 8,169
2022-03-31 $89,739 18,465
2021-12-31 $20,399 3,400
2021-09-30 $30,497 4,525
2021-06-30 $20,677 2,575
2021-03-31 $20,910 2,089
2020-12-31 $64,647 5,931
2020-09-30 $149,335 16,970
2020-06-30 $50,212 2,342
2020-03-31 $13,085 353